Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan

Table 4 The attributable fraction for early pubertal development

Percentiles	P0–9	P10–24	P25–49	P50–74	P75–89	P90+
Concentration of TCS (μg/g creatinine)	0	0	0	11.08	40.51	67,30
HR at prevailing exposure	0	0	0	1	1.17	1.17
Total number of cases	281,923
Sensitivity analysis
Total number of cases (based on [41] alone)	112,769
Total number of cases (based on [42] alone)	0

ISSN: 1476-069X